{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T01:16:42Z","timestamp":1783214202610,"version":"3.54.6"},"reference-count":57,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019702","name":"Tokyo Metropolitan Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtct.2026.03.036","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:19:44Z","timestamp":1774883984000},"page":"903.e1-903.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Impact of BK Polyomavirus Viremia Detected by Multiplex Plasma PCR Following Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4860-4332","authenticated-orcid":false,"given":"Ryo","family":"Hasunuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8550-4181","authenticated-orcid":false,"given":"Hiroaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3873-8268","authenticated-orcid":false,"given":"Daichi","family":"Sadato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizuko","family":"Hirama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Jinguji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-8189","authenticated-orcid":false,"given":"Kaoru","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7436-972X","authenticated-orcid":false,"given":"Takashi","family":"Toya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8910-0021","authenticated-orcid":false,"given":"Yuho","family":"Najima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6658-7543","authenticated-orcid":false,"given":"Tomomi","family":"Toubai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3844-9673","authenticated-orcid":false,"given":"Kyoko","family":"Haraguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9608-9841","authenticated-orcid":false,"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.03.036_bib0001","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.03.036_bib0002","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bbmt.2008.04.016","article-title":"Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome","volume":"14","author":"de Pagter","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0003","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/bmt.2013.33","article-title":"Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience","volume":"48","author":"Yilmaz","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0004","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s00277-019-03742-7","article-title":"Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies","volume":"98","author":"Gao","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2026.03.036_bib0005","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1016\/S1473-3099(25)00069-6","article-title":"Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies","volume":"25","author":"Ljungman","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jtct.2026.03.036_bib0006","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41409-019-0752-5","article-title":"Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation: the Japan Society for Hematopoietic Cell Transplantation","volume":"55","author":"Ogata","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0007","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3324\/haematol.2016.144428","article-title":"Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines","volume":"101","author":"Styczynski","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.03.036_bib0008","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2016-10-748426","article-title":"The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality","volume":"129","author":"Hill","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.03.036_bib0009","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/v15040928","article-title":"Longitudinal detection of twenty DNA and RNA viruses in allogeneic hematopoietic stem cell transplant recipients plasma","volume":"15","author":"Zanella","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jtct.2026.03.036_bib0010","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbmt.2014.01.014","article-title":"BK virus disease after allogeneic stem cell transplantation: a cohort analysis","volume":"20","author":"Rorije","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0011","first-page":"12","article-title":"ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients","volume":"73","author":"Cesaro","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jtct.2026.03.036_bib0012","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/bmt.2013.235","article-title":"High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"49","author":"Gilis","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0013","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41409-022-01665-y","article-title":"Incidence, risk factors and outcome of BK virus hemorrhagic cystitis following allogenic hematopoietic cell transplantation: a retrospective cohort study","volume":"57","author":"Saade","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0014","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/bmt.2015.162","article-title":"Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival","volume":"50","author":"Lunde","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13101","article-title":"Severe hemorrhagic cystitis caused by the BK polyomavirus is associated with decreased survival post-allogeneic hematopoietic stem cell transplantation","volume":"21","author":"Kerbauy","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jtct.2026.03.036_bib0016","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1093\/cid\/ciz1194","article-title":"The natural history of BK polyomavirus and the host immune response after stem cell transplantation","volume":"71","author":"Laskin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2026.03.036_bib0017","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00277-024-05707-x","article-title":"Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation","volume":"103","author":"Umezawa","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2026.03.036_bib0018","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1182\/blood-2010-10-312934","article-title":"The importance of neovascularization and its inhibition for allogeneic hematopoietic stem cell transplantation","volume":"117","author":"Penack","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.03.036_bib0019","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/s41409-020-0852-2","article-title":"Vascular endothelial syndromes after HCT: 2020 update","volume":"55","author":"Carreras","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0020","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0021","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2026.03.036_bib0022","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1182\/bloodadvances.2025017097","article-title":"Outcomes with third-party virus-specific T cells after the use of single-antigen cell lines to predict HLA restriction","volume":"9","author":"Rubinstein","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.03.036_bib0023","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2012-03-418202","article-title":"A disease risk index for patients undergoing allogeneic stem cell transplantation","volume":"120","author":"Armand","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.03.036_bib0024","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtct.2022.11.015","volume":"29","author":"Schoettler","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.03.036_bib0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41409-023-01992-8","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)","volume":"58","author":"Mohty","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0026","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0027","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bbmt.2007.09.003","article-title":"HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Du","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0028","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/tan.13966","article-title":"Specific donor HLA allotypes as predictors of cytomegalovirus disease risk in acute myeloid leukemia","volume":"96","author":"Min","year":"2020","journal-title":"Hla"},{"key":"10.1016\/j.jtct.2026.03.036_bib0029","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13879","article-title":"Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Prem","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jtct.2026.03.036_bib0030","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood.2022017650","article-title":"HLA-E-restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD","volume":"141","author":"Vietzen","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.03.036_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005903","article-title":"Clinically relevant reactivation of polyomavirus BK (BKPyV) in HLA-A02-positive renal transplant recipients is associated with impaired effector-memory differentiation of BKPyV-specific CD8+ T cells","volume":"12","author":"van Aalderen","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jtct.2026.03.036_bib0032","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/ajt.13252","article-title":"The loss of BKV-specific immunity from pretransplantation to posttransplantation identifies kidney transplant recipients at increased risk of BKV replication","volume":"15","author":"Schachtner","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0033","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/TP.0000000000001314","article-title":"Increased Frequency of BK virus-specific polyfunctional CD8+ T cells predict successful control of BK viremia after kidney transplantation","volume":"101","author":"Schaenman","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2026.03.036_bib0034","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5045\/kjh.2012.47.1.44","article-title":"Factors influencing lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation in children","volume":"47","author":"Bae","year":"2012","journal-title":"Korean J Hematol"},{"key":"10.1016\/j.jtct.2026.03.036_bib0035","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/ndt\/gft298","article-title":"HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia","volume":"28","author":"Masutani","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0036","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.transproceed.2017.01.009","article-title":"Prevalence and risk factors of BK viremia in patients with kidney transplantation: a single-center experience from Turkey","volume":"49","author":"Dogan","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jtct.2026.03.036_bib0037","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/immuno5020016","article-title":"Pre- and post-transplant anti-BKV IgG responses and HLA associations in BK virus reactivation among renal transplant recipients","volume":"5","author":"Fallatah","year":"2025","journal-title":"Immuno"},{"key":"10.1016\/j.jtct.2026.03.036_bib0038","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/TP.0000000000002376","article-title":"Reduced risk of BK polyomavirus infection in HLA-B51-positive kidney transplant recipients","volume":"103","author":"Wunderink","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2026.03.036_bib0039","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/v12121417","article-title":"The role of HLA and KIR immunogenetics in BK virus infection after kidney transplantation","volume":"12","author":"Burek Kamenaric","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jtct.2026.03.036_bib0040","doi-asserted-by":"crossref","first-page":"e2378","DOI":"10.1002\/rmv.2378","article-title":"The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: a systematic review and meta-analysis","volume":"33","author":"Dobrijevic","year":"2023","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jtct.2026.03.036_bib0041","article-title":"HLA, immune response, and susceptibility to COVID-19","volume":"11","author":"Tavasolian","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2026.03.036_bib0042","doi-asserted-by":"crossref","first-page":"10826","DOI":"10.1128\/JVI.00804-11","article-title":"Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy","volume":"85","author":"Kuniholm","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jtct.2026.03.036_bib0043","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1182\/bloodadvances.2022007005","article-title":"Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy","volume":"6","author":"Hasan","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.03.036_bib0044","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.bmt.1705133","article-title":"Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with the HLA-A*02 or HLA-A*24 phenotype undergoing hematopoietic stem cell transplantation","volume":"36","author":"Morita","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2025.09.029","article-title":"Expression of HLA-B*35 is associated with an increased risk of CMV viremia and clinically significant CMV infection following PTCy-based hematopoietic cell transplantation","volume":"32","author":"Little","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.03.036_bib0046","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.humimm.2009.05.003","article-title":"HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen","volume":"70","author":"Ramaswami","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jtct.2026.03.036_bib0047","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1099\/vir.0.82094-0","article-title":"T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus","volume":"87","author":"Li","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jtct.2026.03.036_bib0048","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.18632\/oncotarget.12387","article-title":"Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance","volume":"8","author":"Mani","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtct.2026.03.036_bib0049","doi-asserted-by":"crossref","first-page":"eadt3499","DOI":"10.1126\/sciadv.adt3499","article-title":"Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation","volume":"11","author":"Chevalier","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtct.2026.03.036_bib0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10875-025-01901-2","article-title":"BK virus-specific T cell response associated with HLA genotypes, RhD status, and CMV or EBV serostatus in healthy donors for optimized cell therapy","volume":"45","author":"Mora-Buch","year":"2025","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtct.2026.03.036_bib0051","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.bbmt.2014.07.003","article-title":"Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning","volume":"20","author":"Reshef","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.036_bib0052","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2026.03.036_bib0053","article-title":"Immune reconstitution after allogeneic haematopoietic cell transplantation: from observational studies to targeted interventions","volume":"9","author":"Yanir","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jtct.2026.03.036_bib0054","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3324\/haematol.2013.087338","article-title":"Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation","volume":"99","author":"Uhlin","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.03.036_bib0055","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood.V98.4.972","article-title":"Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell\u2013depleted SCT","volume":"98","author":"van Esser","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.03.036_bib0056","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/v16081294","article-title":"EBV reactivation and disease in allogeneic hematopoietic stem cell transplant (HSCT) recipients and its impact on HSCT outcomes","volume":"16","author":"Law","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.jtct.2026.03.036_bib0057","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.bbmt.2018.12.753","article-title":"Incidence of adenovirus infection in hematopoietic stem cell transplantation recipients: findings from the advance study","volume":"25","author":"Sedlacek","year":"2019","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726002526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726002526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:38:18Z","timestamp":1783211898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726002526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666636726002526"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.03.036","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Impact of BK Polyomavirus Viremia Detected by Multiplex Plasma PCR Following Allogeneic Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}